中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/02/22 | 1,287 | 1,294 | 1,280 | 1,282 | ±0 | ±0% | 1,741,300 |
2012/02/21 | 1,274 | 1,290 | 1,272 | 1,282 | +11 | +0.9% | 785,900 |
2012/02/20 | 1,280 | 1,283 | 1,271 | 1,271 | +6 | +0.5% | 666,100 |
2012/02/17 | 1,269 | 1,271 | 1,256 | 1,265 | +15 | +1.2% | 831,100 |
2012/02/16 | 1,253 | 1,259 | 1,245 | 1,250 | -2 | -0.2% | 947,900 |
2012/02/15 | 1,244 | 1,260 | 1,241 | 1,252 | +4 | +0.3% | 1,451,600 |
2012/02/14 | 1,243 | 1,251 | 1,233 | 1,248 | +7 | +0.6% | 901,600 |
2012/02/13 | 1,247 | 1,250 | 1,238 | 1,241 | -2 | -0.2% | 770,600 |
2012/02/10 | 1,244 | 1,247 | 1,236 | 1,243 | -1 | -0.1% | 1,370,900 |
2012/02/09 | 1,248 | 1,248 | 1,233 | 1,244 | +4 | +0.3% | 1,315,400 |
2012/02/08 | 1,240 | 1,245 | 1,235 | 1,240 | +7 | +0.6% | 1,182,100 |
2012/02/07 | 1,225 | 1,243 | 1,225 | 1,233 | +4 | +0.3% | 806,300 |
2012/02/06 | 1,238 | 1,239 | 1,226 | 1,229 | +3 | +0.2% | 767,000 |
2012/02/03 | 1,248 | 1,249 | 1,223 | 1,226 | -28 | -2.2% | 1,339,700 |
2012/02/02 | 1,235 | 1,267 | 1,226 | 1,254 | +40 | +3.3% | 1,707,100 |
2012/02/01 | 1,215 | 1,224 | 1,205 | 1,214 | +3 | +0.2% | 809,200 |
2012/01/31 | 1,205 | 1,213 | 1,199 | 1,211 | +9 | +0.7% | 909,200 |
2012/01/30 | 1,184 | 1,202 | 1,176 | 1,202 | +17 | +1.4% | 714,300 |
2012/01/27 | 1,200 | 1,204 | 1,185 | 1,185 | -12 | -1% | 1,362,400 |
2012/01/26 | 1,196 | 1,204 | 1,195 | 1,197 | +3 | +0.3% | 722,500 |
2012/01/25 | 1,217 | 1,217 | 1,191 | 1,194 | -21 | -1.7% | 1,336,200 |
2012/01/24 | 1,210 | 1,219 | 1,201 | 1,215 | +5 | +0.4% | 739,700 |
2012/01/23 | 1,198 | 1,213 | 1,195 | 1,210 | +14 | +1.2% | 792,800 |
2012/01/20 | 1,216 | 1,216 | 1,194 | 1,196 | -1 | -0.1% | 1,061,400 |
2012/01/19 | 1,202 | 1,207 | 1,191 | 1,197 | +1 | +0.1% | 1,037,300 |
2012/01/18 | 1,194 | 1,205 | 1,181 | 1,196 | +2 | +0.2% | 991,900 |
2012/01/17 | 1,204 | 1,209 | 1,188 | 1,194 | -6 | -0.5% | 747,700 |
2012/01/16 | 1,205 | 1,205 | 1,195 | 1,200 | -17 | -1.4% | 495,400 |
2012/01/13 | 1,206 | 1,222 | 1,202 | 1,217 | +26 | +2.2% | 1,951,300 |
2012/01/12 | 1,205 | 1,205 | 1,187 | 1,191 | -13 | -1.1% | 775,200 |
2012/01/11 | 1,210 | 1,212 | 1,193 | 1,204 | -2 | -0.2% | 784,000 |
2012/01/10 | 1,210 | 1,224 | 1,202 | 1,206 | ±0 | ±0% | 788,800 |
2012/01/06 | 1,217 | 1,228 | 1,200 | 1,206 | -10 | -0.8% | 1,141,800 |
2012/01/05 | 1,223 | 1,223 | 1,210 | 1,216 | -20 | -1.6% | 1,596,500 |
2012/01/04 | 1,270 | 1,282 | 1,231 | 1,236 | -33 | -2.6% | 2,576,800 |
2011/12/30 | 1,273 | 1,277 | 1,263 | 1,269 | -2 | -0.2% | 548,100 |
2011/12/29 | 1,259 | 1,273 | 1,249 | 1,271 | +11 | +0.9% | 726,400 |
2011/12/28 | 1,261 | 1,265 | 1,232 | 1,260 | -18 | -1.4% | 1,092,000 |
2011/12/27 | 1,280 | 1,282 | 1,274 | 1,278 | -4 | -0.3% | 427,100 |
2011/12/26 | 1,290 | 1,293 | 1,278 | 1,282 | +6 | +0.5% | 445,200 |
2011/12/22 | 1,277 | 1,289 | 1,270 | 1,276 | -1 | -0.1% | 783,400 |
2011/12/21 | 1,256 | 1,277 | 1,247 | 1,277 | +32 | +2.6% | 975,000 |
2011/12/20 | 1,249 | 1,252 | 1,239 | 1,245 | -3 | -0.2% | 750,600 |
2011/12/19 | 1,247 | 1,258 | 1,241 | 1,248 | +1 | +0.1% | 716,000 |
2011/12/16 | 1,237 | 1,258 | 1,233 | 1,247 | +10 | +0.8% | 941,500 |
2011/12/15 | 1,229 | 1,244 | 1,229 | 1,237 | +1 | +0.1% | 678,300 |
2011/12/14 | 1,224 | 1,246 | 1,222 | 1,236 | +2 | +0.2% | 770,300 |
2011/12/13 | 1,232 | 1,246 | 1,218 | 1,234 | -17 | -1.4% | 675,400 |
2011/12/12 | 1,244 | 1,253 | 1,235 | 1,251 | +18 | +1.5% | 722,200 |
2011/12/09 | 1,216 | 1,238 | 1,216 | 1,233 | -7 | -0.6% | 3,703,500 |
3251~
3300
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム